Neonc Technologies Holdings, Inc. (NTHI): EPS (Diluted)

Annual figures by period end, from SEC filings.

-$3.20
Year ended 2025-12-31
2024-12-31: -$0.692025-12-31: -$3.20-$3.20
2024-12-31 EPS (Diluted) (USD per share) 2025-12-31
Period endedEPS (Diluted)Change YoYSource filing
2025-12-31-$3.20n/m2026-03-31, From 2025-01-01
2024-12-31-$0.69n/a2026-03-31, From 2024-01-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Diluted)Change YoY
Neonc Technologies Holdings, Inc. (NTHI)2025-12-31-$3.20n/m
Altimmune, Inc. (ALT)2025-12-31-$1.00n/m
Lyell Immunopharma, Inc. (LYEL)2025-12-31-$16.06n/m
Impact Biomedical Inc. (IBO)2025-12-31-$0.38n/m
HCW Biologics Inc. (HCWB)2025-12-31-$10.63n/m
Avalo Therapeutics, Inc. (AVTX)2025-12-31-$5.84n/m
Connect Biopharma Holdings Ltd (CNTB)2025-12-31-$1.00n/m
Inovio Pharmaceuticals, Inc. (INO)2025-12-31-$1.81n/m
Silo Pharma, Inc. (SILO)2025-12-31-$0.50n/m

Compare NTHI, ALT, LYEL, IBO side by side · Screen every company in Pharmaceutical Preparations ↗